documents: FDA-2013-N-0500-0082
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-N-0500-0082 | FDA | FDA-2013-N-0500 | Reference 1 - Joint GPhA PhRMA Letter to Dr Hamburg re Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Public Meeting; Request for Comments; Reopening of the Comment Period | Supporting & Related Material | Background Material | 2015-02-18T05:00:00Z | 2015 | 2 | 2015-02-18T18:01:50Z | 0 | 0 | 0900006481a0854b |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref